Author(s): Rashmi T, M Gnana Ruba Priya, V Murugan

Email(s): rashmiau023@gmail.com

DOI: 10.52711/0974-360X.2022.00069   

Address: Rashmi T1*, M Gnana Ruba Priya2, V Murugan3
1Research Scholar, College of Pharmaceutical Sciences, Dayanandasagar University, Bengaluru-560078, India.
2Associate Professor, College of Pharmaceutical Sciences, Dayanandasagar University, Bengaluru-560078, India.
3Professor and Dean, College of Pharmaceutical Sciences, Dayanandasagar University, Bengaluru-560078, India.
*Corresponding Author

Published In:   Volume - 15,      Issue - 1,     Year - 2022


ABSTRACT:
The heterocyclic fused ring quinazolinone has drawn an enormous consideration owing to its expanded functions in the sector of pharmaceutical chemistry. Quinazolinone is reported for its varied organic actions and compound with complete substitutions furnish at the side of information of a goal with working out of the molecular sorts that will work together with the goal receptors. Quinazolinones is taken into account as a very important chemical for the synthesis of quite a lot of physiological significance and pharmacological utilized molecule.The broad and potent activity of quinazolinone has established it as one of the biologically important scaffolds. This article is an effort to highlight the importance of the quinazolinone in the present context and the promise they hold for the future.


Cite this article:
Rashmi T, M Gnana Ruba Priya, V Murugan. Quinazolinone - A Biologically Active Scaffold. Research Journal of Pharmacy and Technology. 2022; 15(1):419-3. doi: 10.52711/0974-360X.2022.00069

Cite(Electronic):
Rashmi T, M Gnana Ruba Priya, V Murugan. Quinazolinone - A Biologically Active Scaffold. Research Journal of Pharmacy and Technology. 2022; 15(1):419-3. doi: 10.52711/0974-360X.2022.00069   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-1-69


REFERENCES:
1.    Kennedy, John F. An introduction to medicinal chemistry. Carbohydrate Polymers. 2007; 68: 609–10.
2.    Mhaske SB, Argade NP. The chemistry of recently isolated naturally occurring quinazolinone alkaloids.Tetrahedron. 2006; 62: 9787–826.
3.    Wattanapiromsakul C, Forster PI, Waterman PG. Alkaloids and limonoids from Bouchardatianeurococca systematic significance. Phytochem. 2003; 64: 609-21.
4.    Deng Y, Xu R, Ye YJ. Chin. A simple and efficient approach to quinazolinones under mild copper- catalyzed conditions. Pharm Sci. 2000; 9: 116-28.
5.    Dewick PM, Wiley J.Synthetic studies of heterocyclic natural products.Med Nat Prod. 2009: 395-97.
6.    Terashima K, Shimamura H, Kawase A, Tanaka Y, Tanimura T, Kamisaki T, Ishizuka Y, Sato M. Studies on antiulcer effects of 2-Benzylthio-5,6,7,8-tetrahydro-4(3H)-quinazolinones and related compounds. ChemPharmaceu Bulletin. 1995; 43(11): 2021-23.
7.    MahdyHA, IbrahimaMK, MetwalyAM,Belal A, MehanyeABM, El-GamalKMA, El-Sharkawy A, ElhendawyMA, RadwanMM, ElsohlyMA, EissaaIH. Design, synthesis, molecular modeling, in vivo studies, and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers.Bioorg Chem. 2020; 94: 1-25.
8.    Le Y, Gan Y, Fu Y, Liu J, Li W, Zou X, Zhou Z, Wang Z, OuyangG, Yan L. Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment. J Enzyme Inhib Med Chem. 2020; 35(1): 555-64.
9.    Deshmukh SU, Kharat KR, Kadam GG, Pawar RP.Synthesis of quinazolinones derivatives an antiproliferative agent against human lung carcinoma cells.Eur J Chem. 2017; 8(3): 317-20.
10.    Ghodge B, Kshirsagar A, Navghare V. Synthesis, characterization, and investigation of the anti-inflammatory effect of 2,3-disubstituted quinazoline-4(1H)-one. J Basic Applied Sci. 2020; 9: 1-12.
11.    Amin KM, Kamel MM, Anwar MM, Khedr M, Syamb YM. Synthesis, biological evaluation, and molecular docking of novel series of spiro[(2H,3H)quinazoline-2,10-cyclohexan]-4(1H)-one derivatives as anti-inflammatory and analgesic agents. Eur J Med Chem. 2010; 45(6): 2117–31.
12.    Mohamed MS, Kamel MM, Kassem EMM, Abotaleb N, Nofal SM, Ahmed MF. Novel 3-(p-substituted phenyl)-6-bromo-4(3h)-quinazolinone derivatives of promising anti-inflammatory and analgesic properties.Acta Pol PharmDrug Res. 2009; 66(5): 487-500.
13.    Rajan SG, Hardik MT, Giordano T, Williams J, Rogers D,Sudersanam V, Kamala KV. Design, synthesis, and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-𝜅B and AP-1 mediated transcription activation and as potential anti-inflammatory agents.Eur J Med Chem. 2009; 44(5): 2184-89.
14.    Hemalatha K, Girija K. Synthesis of some novel 2, 3-disubstituted quinazolinone derivatives as an analgesic and anti-inflammatory agents.Int J Pharm Pharm Sci. 2011; 3(2): 103-6.
15.    Bojarski AJ, Kowalski P, Kowalska T, Duszynska B, Minol CS, Tatarczynska E, Klodzinska A, Chojnacka-Wo JE. Synthesis and pharmacological evaluation of new arylpiperazines 3-{4-[4-(3-chlorophenyl)-1-piperazinyl]butyl}-quinazolidin-4-one–a dual serotonin 5-HT1A/5-HT2A receptor ligand with an anxiolytic-like activity. Bioorg Med Chem. 2002; 10(12): 3817–27.
16.    Kashaw SK, Kashaw V, Mishra P, Jain NK, Stables JP. Synthesis, anticonvulsant, and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea.Eur J Med Chem. 2009; 44(11): 4335–43.
17.    Ye C, You J, Li XF, You R, Weng Y, Li J, Wang Y. Design, synthesis, and anticoccidial activity of a series of 3-(2-(2-methoxyphenyl)-2-oxoethyl)quinazolinone derivatives. PesticBiochem Physiol. 2010; 97(3): 194–8.
18.    Ugale VG, Patel HM, Wadodkar SG, Bari SB, Shirkhedkar AA, Surana SJ.Quinazolino-benzothiazoles: Fused pharmacophores as anticonvulsant agents. Eur J Med Chem. 2012; 53: 107-13.
19.    Archana, Srivastava VK, Kumar A. Synthesis of newer thiadiazolyl and thiazolidinonyl quinazolin-4(3H)- ones as potential anticonvulsant agents. Eur J Med Chem. 2002; 37(11): 873-82.
20.    Rivero A, Espinoza K, Somanathan R. Syntheses of quinazoline-2,4-dione alkaloids and analogues from MexicanZanthoxylum species. Molecules. 2004; 9: 609-16.
21.    Pandeya SN, Sriram D, Nath G, Clercq ED. Synthesis antibacterial, antifungal, and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one. PharmaActaHelv. 1999; 74(1): 11–17.
22.    Asadi P, Khodarahmi G, Najafabadi AJ, Saghaie L, Hassanzadeh F. Synthesis, characterization, molecular docking studies, and biological evaluation of some novel hybrids based on quinazolinone, benzofuran and imidazolium moieties as potential cytotoxic and antimicrobial agents. Iran J Basic Med Sci. 2017; 20(9): 975-89.
23.    Zayed MF, Hassan MH. Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents. Saudi Pharm J. 2014; 22: 157-62.
24.    Anwar A, Shahbaz MS, Saad SM, Khan KKM, Siddiqui R, Khan NA. Novel antiacanthamoebic compounds belonging to quinazolinones. Euro J Med Chem. 2019; 182: 111-17.
25.    Saeedi M, Khanaposhtani MM, Pourrabia P, Razzaghi N, Ghadima R, Imanparast S, Faramarzi MA, Bandarian F, Esfahani EN, Safavi M, Rastegar H, Larijani B, Mahdavi M, Akbarzadeh T. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new antidiabetic agents:In vitroα-glucosidase inhibition, kinetic and docking study. Bioorg Chem. 2019: 83; 161-9.
26.    Birhan YS, Bekhit AA, Hymete A.Synthesis, and antileishmanial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives. Org Med ChemLett. 2014; 4(10): 1-7.
27.    Myangar KN, Akhaja TN, Naik DR, Raval JP. Novel piperazinyl-quinazoline-4-one analogs: design, synthesis, and evaluation of in vitro biological activity. ChemSci Trans. 2012; 1(3): 688-96.
28.    Reddy VR, Rao NR, Reddy RR, Suthakaran R. Microwave-assisted synthesis, characterization, and pharmacological evaluation of imidazolo quinazoline-4-one derivatives. Int J Pharm Sci Rev Res. 2014; 29(2): 1-4.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available